CRSP Earnings Crispr Therapeutics Ag
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.28 | 2026-05-04 | 10-Q |
| FY 2025 | 2025-12-31 | -6.47 | 2026-02-12 | 10-K |
| Q3 2025 | 2025-09-30 | -5.12 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -3.98 | 2025-08-04 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.58 | 2026-05-04 | 10-Q |
| FY 2025 | 2024-12-31 | -4.34 | 2026-02-12 | 10-K |
| Q3 2025 | 2024-09-30 | -3.92 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.92 | 2025-08-04 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.43 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | -1.94 | 2026-02-12 | 10-K |
| Q3 2024 | 2023-09-30 | -3.07 | 2024-11-05 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.66 | 2024-08-05 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.67 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -8.36 | 2025-02-11 | 10-K |
| Q3 2023 | 2022-09-30 | -6.96 | 2023-11-06 | 10-Q |
| Q2 2023 | 2022-06-30 | -4.72 | 2023-08-07 | 10-Q |
| Q1 2023 | 2022-03-31 | -2.32 | 2023-05-08 | 10-Q |
| FY 2023 | 2021-12-31 | 4.70 | 2024-02-21 | 10-K |
| Q3 2022 | 2021-09-30 | 6.44 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | 8.03 | 2022-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.